Status: Recruiting
Observational Study to Evaluate the Efficacy of OLMETEC Tab on Nocturnal Blood Pressure Control in Patients With Stage Ⅰ Hypertension
This is a prospective, multicenter, observational study to evaluate the effectiveness of Olmetec® or Olmetec Plus® on nocturnal blood pressure control in Korean patients with stage 1 hypertension. Patients receiving Olmetec-based therapy in routine clinical practice will be followed to assess changes in ambulatory blood pressure, including nocturnal blood pressure and blood pressure variability.
Participants needed: 12,000
Trial details
Age: 19+Biological sex: AllType: ObservationalSponsor: Daewoong Pharmaceutical Co. LTD.Updated: Apr 7, 2026Locations: 1
Eligibility criteria
Adults aged ≥19 years [+4]
Patients with secondary hypertension [+6]